Long-term results of treatment of chronic hepatitis B, C and D with interferon- α in renal allograft recipients

1998 ◽  
Vol 11 (0) ◽  
pp. S135-S139 ◽  
Author(s):  
M. Durlik ◽  
Z. Gaciong ◽  
D. Rowi ` ska ◽  
Z. Rancewicz ◽  
D. Lewandowska ◽  
...  
1998 ◽  
Vol 11 (s1) ◽  
pp. S135-S139 ◽  
Author(s):  
M. Durlik ◽  
Z. Gaciong ◽  
D. Rowińska ◽  
Z. Rancewicz ◽  
D. Lewandowska ◽  
...  

2007 ◽  
Vol 52 (3) ◽  
pp. 727-731 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Ahmet Danalioglu ◽  
Kadir Demir ◽  
Cetin Karaca ◽  
Filiz Akyuz ◽  
...  

2017 ◽  
pp. 47-51
Author(s):  
R. G. MYAZIN

Modern approaches to the prevention and treatment of chronic hepatitis B are based on the use of vaccination of the population, on the one hand, and rational choice of antiviral therapy schemes in patients - on the other. This allows the physician to predict results of treatment and preventive measures. Modern analogues of nucleosides, in particular, Entecavir, has high efficacy, good tolerance and high safety profile when used in long term conditions.


1996 ◽  
Vol 3 (5) ◽  
pp. 253-260 ◽  
Author(s):  
V. Martino ◽  
F. Lunel ◽  
J.F. Cadranel ◽  
C. Hoang ◽  
Y. Parlier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document